Back

Triple therapy is still needed in patients with atrial fibrillation undergoing PCI - PRO.

31 August 2020 (10:33 - 10:42)
Organised by:
Congress Presentation Part of: Controversies in Antithrombotic Therapy: Is Triple Therapy Still Needed in Patients with Atrial Fibrillation Undergoing PCI? Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Gilles Montalescot

Sorbonne University, Paris (France)

2 More presentations in this session

Presentation thumbnail
Triple therapy is still needed in patients with atrial fibrillation undergoing PCI - CON.
Professor C. Cannon (Boston, US)
Slides Video
Presentation thumbnail
Triple therapy is still needed in patients with atrial fibrillation undergoing PCI - Discussion.
Video

Access the full session

Session thumbnail
Controversies in Antithrombotic Therapy: Is Triple Therapy Still Needed in Patients with Atrial Fibrillation Undergoing PCI?
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 10:33 CET
You may be interested in
thumbnail
Congress Presentation
Portuguese experience with dual and triple therapy in atrial fibrillation and acute coronary syndrome patients
29 June 2021
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Presentation
National dispensing of evidence-based treatment for New Zealand patients before and after peripheral arterial or percutaneous coronary procedures; undertreatment in plain sight.
1 September 2024
thumbnail
Congress Presentation
Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources